Diagnostic value of the gonadal biopsy in the disorders of sex development;Valor de la biopsia gonadal en el diagnóstico de los desórdenes del desarrollo sexual

Actas Urologicas Espanolas

Volumn 31, Issue 9, 2007, Pages 1056-1075

  Nistal, M ^a,b   Garcia Fernandez E ^a   Marino Enriquez A ^a   Serrano, A ^c   Regadera, J ^b   Gonzalez Peramato P ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

Author keywords

Anorqui; Disgenesia gonadal; Pscudohermafroditismo

Indexed keywords

BIOPSY; CONGENITAL MALFORMATION; FEMALE; FEMALE GENITAL TRACT TUMOR; GENETICS; GONAD; HUMAN; MALE; MALE GENITAL TRACT TUMOR; PATHOLOGY; REVIEW; SEX DIFFERENTIATION; SEX DIFFERENTIATION DISORDER;

BIOPSY; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; GONADS; HUMANS; MALE; SEX DIFFERENTIATION; SEX DIFFERENTIATION DISORDERS;

EID: 41649112817     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-4806(07)73767-1     Document Type: Article

References (155)

1. Bidarkar SS, Hutson JM. Evaluation and management of the abnormal gonad. Semin Pediatr Surg. 2005;14(2):118-123.
2. Hiort O, Holterhus PM. The molecular basis of male sexual differentiation. Eur J Endocrinol. 2000;142(2):101-110.
3. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, et al. WT-1 is required for early kidney development. Cell. 1993:74(4):679-691.
4. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991;67(2):437-447.
5. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet. 1997;17(4): 467-470.
6. Haney NA, Ball SG, Clement-Jones M, Hagan DM, Strachan T, Lindsay S, et al. Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech Dev. 1999;87(1-2):175-180.
7. Lim HN, Hawkins JR. Genetic control of gonadal differentiation. Baillieres Clin Endocrinol Metab. 1998 Apr: 12(1): 1-16.
8. Kim Y, Capel B. Balancing the bipotential gonad between alternative organ fates: A new perspective on an old problem. Dev Dyn. 2006 Sep;235(9):2292-300.
9. Berta P, Hawkins JR, Sinclair AH, Taylor A, Griffiths BL, Goodfellow PN, et al. Genetic evidence equating SRY and the testis-determining factor. Nature. 1990;348(6300): 448-450.
10. Salas-Cortes L, Jaubert F, Barbaux S, Nessmann C, Bono MR, Fellous M, et al. The human SRY protein is present in fetal and adult Sertoli cells and germ cells. Int J Dev Biol. 1999;43(2):135-140.
11. Haqq CM, King CY, Ukiyama E, Falsafi S, Haqq TN, Donahoe PK, et al. Molecular basis of mammalian sexual determination: activation of Mullerian inhibiting substance gene expression by SRY. Science. 1994;266(5190):1494-500.
12. Foster JW, Dominguez-Steglich MA, Guioli S, Kowk G, Weller PA, Stevanovic M, et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature. 1994;372(6506):525-530.
13. Huang B, Wang S, Ning Y, Lamb AN, Bartley J. Autosomal XX sex reversal caused by duplication of SOX9. Am J Med Genet. 1999;87(4):349-353.
14. Koopman P. Sex determination: a tale of two Sox genes. Trends Genet. 2005;21(7):367-370.
15. Wolf U. The molecular genetics of human sex determination. J Mol Med. 1995;73(7):325-331.
16. Baumstark A, Barbi G, Djalali M, Geerkens C, Mitulla B, Mattfeldt T, et al. X-p duplications with and without sex reversal. Hum Genet, 1996;97(1):79-86.
17. Bennett CP, Docherty Z, Robb SA, Ramani P, Hawkins JR, Grant D. Deletion 9p and sex reversal. J Med Genet. 1993; 30(6):518-520.
18. Wilkie AOM, Campbell FM, Daubeney P, Grant DB, Daniels RJ, Mullarkey M, et al. Complete and partial XY sex reversal associated with terminal deletion of 10q: report of 2 cases and literature review. Am J Med Genet. 1993;46(5): 597-600.
19. Merchant-Larios H, Moreno-Mendoza N, Buehr M. The role of the mesonephros in cell differentiation and morphogenesis of the mouse fetal testis. Int J Dev Biol. 1993;37(3): 407-415.
20. Capel B, Albrecht K, Washburn LL, Eicher EM. Migration of mesonephric cells into the mammalian gonad depends on Sry. Mechanisms Develop 1999:84(1-2):127-131.
21. Witschi E. Migration of the germ cells of human embryos from the yolk sac to the primitive gonadal fold. Carnegie Inst Wash Contrib Embryol. 1948;209:67-80.
22. Fujimoto T, Miyayama V, Fuyuta M. The origin, migration and fine morphology of human primordial germ cells. Anal Rec. 1977;188(3):315-329.
23. Satoh M. Histogenesis and organogenesis of the gonad in human embryos. J Anat. 1991;177:85-107.
24. Merchant-Larios H, Moreno-Mendoza N, Mesonephric stromal cells differentiate into Leydig cells in the mouse fetal testis. Exp Cell Res. 1998;244(1):230-238.
25. Taketo T. Production of Müllerian-inhibiting substance (MIS) and sulfated glycoprotein-2 (SGP-2) associated with testicular differentiation in the XX mouse gonadal graft. Ann N Y Acad Sci. 1991;637:74-89.
26. Byskov AG. Differentiation of the mammalian embryonic gonad. Physiol Rev. 1986;66(1):71-117.
27. Kremer H, Kraaij R, Toledo SPA, Post M, Fridman JB, Hayashida CY, et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet. 1995;9(2):160-164.
28. Laue L, Wu, SM, Kudo M, Hsueh AJW, Cutler GB Jr, Griffin JE, et al. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet. 1995;4(8):1429-1433.
29. Migeon CJ, Berkovitz GD, Brown TR, Wilkins L. The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. 4th ed. Springfield: C.C. Thomas, 1994.
30. Larsen WJ. Human Embryology. London: Churchill Livingstone, 1993.
31. Lee MM, Donahoe PK. Müllerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev. 1993;14(2):152-164.
32. Josso N, Picard JY. Anti-müllerian hormone. Physiol Rev. 1986 Oct;66(4):1038-1090.
33. Cohen-Haugenauer O, Picard JY, Mattei MG, Serero S, Neguyen VC, de Tand MF, et al. Mapping of the gene for anti-müllerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet. 1987;44(1):2-6.
34. Tran D, Muesy-Dessole N, Josso N. Anti-Müllerian hormone is a functional marker of foetal Sertoli cells. Nature. 1977;269(5627):411-412.
35. Schwindt B, Doyle LW, Hutson JM. Serum levels of müllerian inhibiting substance in preterm and term male neonates. J Urol. 1997; 158(2):610-612.
36. Rey R, Schleicher G, Josso N. Anti-müllerian hormone secretion during fetal and postnatal human testicular development. Frontiers Endocrinol. 1995;10:37-47.
37. Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA. Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: a link to the sex determination cascade. Cell. 1994;77(5):651-661.
38. Barbara PS, Moniot B, Poulat F, Boizet B, Berta P. Steroidogenic factor-1 regulates transcription of the human anti-mullerian hormone receptor. J Biol Chem. 1998;273 (45):29654-29660.
39. Rey R, Josso N. Regulation of testicular anti-Müllerian hormone secretion. Eur J Endocrinol. 1996;135(2): 144-152.
40. Musnsterberg A, Lovelll-Badge R. Expression of the mouse anti-müllerian hormone gene suggests a role in both male and female sexual differentiation. Development. 1991;113 (2):613-624.
41. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl. 1992;13(6): 465-475.
42. Eskola V, Nikula H, Huhtaniemi I. Age-related variation of follicle-stimulating hormone stimulated cAMP production, protein kinase C activity and their interactions on the rat testis. Mol Cell Endocrinol. 1993;93(2):143-148.
43. Ketola I, Pentikainen V, Vaskivuo T, Iivesmaki V, Herva R, Dunkel L, et al. Expression of transcription factor GATA-4 during human testicular development and disease. J Clin Endocrinol Metab. 2000;85(10):3925-3931.
44. Josso N, Briard ML. Embryonic testicular regression syndrome. Variable phenotypic expression in siblings. J Pediatr. 1980;97(2):200-204.
45. Maciel-Guerra AT, Farah SB, Garmes HM, Pinto Junior W, Bustorff da Silva JM, Baptista MT, et al. True agonadism: report of a case analyzed with Y-specific DNA probes. Am J Med Genet. 1991;41(4):444-445.
46. Devriendt K, Deloof E, Moerman P, Legius E, Vanhole C, De Zegher F, et al. Diaphragmatic hernia in Denys-Drash syndrome. Am J Med Genet. 1995;57(1):97-101.
47. Manouvrier-Hanu S, Besson R, Cousin L, Jeanpierre C, Kacet N, Cartigny M, et al. Sex reversal and diaphragmatic hernia in phenotypicaly female sibs with normal XY chromosomes. J Med Genet. 2000;37(4):315-318.
48. Zenteno JC, Jimenez AL, Canto P, Valdez H, Mendez JP, Kofman-Alfaro S. Clinical expression and SRY gene analysis in XY subjets lacking gonadal tissue. Am J Med Genet. 2001;99(3):244-247.
49. Macayran JF, Doroshow RW, Phillips J, Sinow RM, Furst BA, Smith LM, et al. PAGOD syndrome: eighth case and comparison to animal models of congenital vitamin A deficiency. Am J Med Genet. 2002;108(3):229-234.
50. Kennerknecht I, Sorgo W, Oberhoffer R, Teller WM, Mattfeldt T, Negri G, et al. Familial occurrence of agonadism and multiple internal malformations in phenotypically normal girls with 46,XY and 46,XX karyotypes, respectively: a new autosomal recessive syndrome. Am J Med Genet. 1993;47(8):1166-1170.
51. Silengo M, Del Monaco A, Linari A, Lala R. Low birth-weight, microcephalic malformation syndrome in a 46,XX girl and her 46,XY sister with agonadism: third report of the Kennerknecht syndrome or autosomal recessive Seckel-like syndrome with previously undescribed genital anomalies. Am J Med Genet. 2001;101(3):275-278.
52. Kushnick T, Wiley JE, Palmer SM. Agonadism in a 46,XY patient with CHARGE association. Am J Med Genet. 1992; 42(1):96-99.
53. Bergada C, Cleveland WW, Jones HW Jr, Wilkins L. Variants of embryonic testicular dysgenesis: bilateral anorchia and the syndrome of rudimentary tetes. Acta Endocrinol. 1962;40:521-536.
54. Najjar SS, Takla RJ, Nassar VH. The syndrome of rudimentary testes: occurrence in five siblings. J Pediatr. 1974;84(1):119-122.
55. Acquafredda A, Vassal J, Job JC. Rudimentary testes syndrome revisited. Pediatrics. 1987;80(2):209-214.
56. Gracia R, Nistal M, Jara P, LLedó G, Jover P. Dos casos de Sindrome de Hanhart. Uno de ellos con anorquía. An Esp Pediat. 1973;6:333-339.
57. Kirschner MA, Jacobs JB, Fraley EE. Bilateral anorchia with persistent testosterone production. N Engl J Med. 1970;282(5):240-244.
58. De Rosa M, Lupoli G, Mennitti M, Zarrilli S, Mirone V, Lombardi G. Congenital bilateral anorchia: clinical, hormonal and imaging study in 12 cases. Andrologia. 1996;28(5):281-285.
59. Lobaccaro JM, Medlej R, Berta P, Belon C, Galifer RB, Guthmann JP, et al. PCR analysis and sequencing of the SRY sex determining gene in four patients with bilateral congenital anorchia. Clin Endocrinol. 1993;38(2):197-201.
60. Parigi GB, Bardoni B, Avoltini V, Caputo MA, Bragheri R. Is bilateral congenital anorchia genetically determined?. Eur J Pediatr Surg. 1999;9(5):312-315.
61. Abeyaratne MR, Aherne WA, Scott JE. The vanishing testis. Lancet. 1969;2(7625):822-824.
62. Tosi SE, Morin LJ. The vanishing testis syndrome. Indications for conservative therapy. J Urol. 1976;115(6): 758-759.
63. Sparnon A, Guiney EJ, Puri P. The vanishing testis. Pediatr Surg Int. 1986;1:227-228.
64. Belman AB, Rushton HG. Is the vanished testis always a scrotal event?. BJU Int. 2001;87(6):480-483.
65. Vinci G, Anjot MN, Trivin C, Lottmann H, Brauner R, McElreavey K. An analysis of the genetic factors involved in testicular descent in a cohort of 14 male patients with anorchia. J Clin Endocrinol Metab. 2004;89(12):6282-6285.
66. Amelar RD. Anorchism without eunuchism. J Urol. 1956; 76(2):174-178.
67. Honore LH. Unilateral anorchism. Report of 11 cases with discussion of etiology and pathogenesis. Urology. 1978;11 (3):251-254.
68. Wright JE. The "atrophic" testicular remnant. Pediatr Surg Int. 1986;1:229-231.
69. Schned AR, Cendron M. Pathologic findings in the vanishing testis syndrome. J Urol Pathol. 1997;6:95-107.
70. Kogan SJ. Cryptorchidism. In Kelalis PP, King LR, Belman AB, editors. Clinical Pediatric. Urology. 2th ed. Philadelphia: W.B. Saunders Co. 1985, p 864.
71. Cendron M, Schned AR, Ellsworth PL. Histological evaluation of the testicular nubbin in the vanishing testis syndrome. J Urol. 1998; 160(3Pt2):1161-1163.
72. Turek PJ, Ewalt DH. Snyder HM III, Stampfers D, Blyth B, Huff DS, et al. The absent cryptorchid testis: surgical findings and their implications for diagnosis and etiology. J Urol. 1994;151(33:718-720.
73. Rozanski TA, Wojno KJ, Bloom DA. The remnant orchiectomy. J Urol. 1996;155(2):712-714.
74. Merry C, Sweeney B, Puri P. The vanishing testis: anatomical and histological findings. Eur Urol. 1997;31(1):65-67.
75. Nistal M, Paniagua R, Regadera J, Queizan A. Hyperplasia of spermatic cord nerves: A sign of testicular absence. Urology. 1987;29(4):411-415.
76. Spires SE, Woolums CS, Pulito AR, Spires SM. Testicular regression syndrome: a clinical and pathologic study of 11 cases. Arch Pathol Lab Med. 2000;124(5):694-698.
77. Grady RW, Mitchell ME, Carr MC. Laparoscopic and histologic evaluation of the inguinal vanishing testis. Urology. 1998;52(5):866-869.
78. Matsuoka LY, Wortsman J, McConnachie P. Renal and testicular agenesis in a patient with Darier's disease. Am J Med. 1985;78:873-877.
79. Das S, Amar AD. Ureteral ectopia into cystic seminal vesicle with ipsilateral renal dysgenesis and monorquia. J Urol. 1980;124(4):574-575.
80. Pierson M, Vidaihet M, Wuilbercq L, Wendremaire-Palandri Y, Comescure B. Le syndrome du regression testiculaire totale ou anorchidie. Arch Fr Pediatr. 1983;40(10):767-773.
81. Mathews R, Sheridan ME, Patil U. Neonatal testicular loss secondary to perinatal trauma in breech presentation. BJU Int. 1999;83(9):1069-1070.
82. Nowakowski H. Bilateral testicular atrophy as a result of scrotal hematoma in the newborn. Acta Endocrinol. 1955;18(4):501-505.
83. Bernasconi S, Ghizzoni L, Panza C, Volta C, Caselli G. Congenital anorchia: natural history and treatment. Horm Res. 1992;37 (suppl 3):50-54.
84. Huff DS, Wu HY, Snyder HM III., Hadziselimovic F, Blythe B. Duckett JW. Evidence in favor of the mechanical (intrauterine torsion) theory over the endocrinopathy (cryptorchidism) theory in the pathogenesis of testicular agenesis. J Urol. 1991;146{2 (Pt 2)):630-631.
85. Marrakchi A, Belhaj L, Boussouf H, Chraibi A, Kadiri A. Pure gonadal dysgenesis XX and XY: observations in fifteen patients. Ann Endocrinol (Paris). 2005;66(6):553-556.
86. Kellermayer R, Halvax L, Czako M, Shahid M. Dhillon VS, Husain SA, et al. A novel frame shift mutation in the HMG box of the SRY gene in a patient with complete 46,XY pure gonadal dysgenesis. Diagn Mol Pathol. 2005;14(3):159-163.
87. Mizuno K, Kojima Y, Tozawa K, Sasaki S, Hayashi Y, Kohri K. Molecular evaluation of the SRY gene for gonads of patients with mixed gonadal dysgenesis. Int J Urol. 2005; 12(7):673-676.
88. Rey R, Al-Attar L, Louis F, Jaubert F, Barbet P, Nihoul-Fékété C. et al. Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules. Am J Pathol. 1996;148(5):1689-1698.
89. Borer JG, Nitti VW, Glassberg KI. Mixed gonadal dysgenesis and dysgenetic male pseudohermaphroditism. J Urol. 1995;153(4):1267-1273.
90. Bergada C, Cleveland WW, Jones HW, Wilkins L. Gonadal histology in patients with male pseudohermaphroditism and atypical gonadal dysgenesis: relation to theories of sex differentiation. Acta Endocrinol. 1962;40:493-520.
91. Sohval AR. Hermaphroditism with "atypical" or "mixed" gonadal dysgenesis. Am J Med. 1964;36:281-292.
92. Smith YR, Stetten G, Charity L, Isacson C, Gearhart JP. Namnoum, AB. Ambiguous genitalia in an elderly woman with a mosaic 45,X/46,X,dic(Y)(Q 11.2) karyotype. Urology. 1996;47(2):259-262.
93. Konrad D, Sossay R, Winklehner HL, Binkert F, Artan S, Scharli AF. Penoscrotai hypospadias and coarctation of the aorta with mixed gonadal dysgenesis. Pediatr Surg Int. 2000;16(3):226-228.
94. Knudtzon J, Aarskog D. 45,X/46,XY mosaicism. A clinical review and report of ten cases. Eur J Pediatr. 1987;146(3): 266-271.
95. Ragg S, Härle M, Scherthan H. Analysis of sex chromosome distribution in the gonadal tissue of a 45,X/47,XYY mosaic by fluorescence in situ hybridization. Mod Pathol. 1995;8(3):295-298.
96. Nonomura N, Nakamura M, Namiki M, Kiyohara H, Mizutani S, Okuyama A, et al. Mixed gonadal dysgenesis: case reports and a review of 65 japanese cases. Arch Androl. 1991;26(1):15-19.
97. Alvarez-Nava F, Soto M, Borjas L, Ortiz R, Rojas A, Martinez S, et al. Molecular analysis of SRY gene in patients with mixed gonadal dysgenesis. Ann Genet. 2001;44(3):155-159.
98. Federman DD. Abnormal Sexual development. Philadelphia: W.B. Saunders Co. 1967.
99. Josso N, Fekete C, Cachin O, Nezelof C, Rappaport R. Persistence of müllerian ducts in male pseudohermaphroditism and its relationship to cryptorchidism. Clin Endocrinol (Oxf). 1983;19(2):247-258.
100. Ribeiro Scolfaro M, Aparecida Cardinalli L, Gabas Stuchi-Perez E, Palandi de Mello M, de Godoy Assumpcao J, Matias Baptista MT, et al. Morphometry and histology of gonads from 13 children with dysgenetic male pseudohermaphroditism. Arch Pathol Lab Med. 2001;125(5): 652-656.
101. Slowikowska-Hilczer J, Szarras-Czapnik M, Kula K. Testicular pathology in 46,XY dysgenetic male pseudohermaphroditism: an approach to pathogenesis of testis cancer. J Androl. 2001;22(5):781-792.
102. Mandell J, Stevens PS, Fried FA. Childhood gonadoblastoma and seminoma in a dysgenetic cryptorchid gonad. J Urol. 1977;117(5):674-675.
103. Belville C, Josso N, Picard J-Y. Persistence of müllerian derivatives in males. Am J Med Genet. 1999;89(4):218-223.
104. Josso N, Belville C, di Clemente N, Picard JY. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Hum Reprod Update. 2005;11(4):351-356.
105. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, et al. Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986;45(5):685-698.
106. Carré-Eusèbe D, Imbeaud S, Harbison M, New MI, Josso N, Picard JY. Variants of the anti-Müllerian hormone gene in a compound heterozygote with the persistent Müllerian duct syndrome and his family. Hum Genet. 1992;90(4):389-394.
107. Cohen-Haguenauer O, Picard JY, Mattei MG, Serero S, Nguyen VC, De Tand MF, et al. Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet. 1987;44(1):2-6.
108. Imbeaud S, Belville C, Messika-Zeitoun L, Rey R, di Clemente N, Josso N, et al. A 27 base-pair deletion of the anti-mullerian type II receptor gene is the most common cause of the persistent mullerian duct syndrome. Hum Mol Genet. 1996;5(9):1269-1277.
109. Pappis C, Constantinides C, Chiotis D, Dacou-Voutetakis C. Persistent müllerian duct structures in cryptorchid male infants, surgical dilemmas. J Pediatr Surg. 1979; 14(2):128-131.
110. Hershlag A, Spitz IM, Hochner-Celnikier D, Haskel Y, Lernau DZ, Nissan S, et al. Persistent mullerian structures in infertile male. Urology. 1986;28(2):138-141.
111. Malayaman D, Armiger G. D'Arcangues C, Lawrence GD. Male pseudohermaphroditism with persistent müllerian and wolffian structures complicated by intra-abdominal seminoma. Urology. 1984;24(1):67-69.
112. Souto CAV, Olivera MD, Telöken C, Paskulin G, Hoffmann K. Persistence of müllerian duct derivative syndrome in 2 male patients with bilateral cryptorchidism. J Urol. 1995;153(5):1637-1638.
113. Imbeaud S, Faure E, Lamarre L, Mattei MG, Di Clemente N, Tizard R, et al. Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor. Nat Genet. 1995; 11(4):382-388.
114. Nilson O. Hernia uteri inguinalis beim Manne. Acta Chir Scand. 1939;83:231-249.
115. Mouli K, McCarthy P, Ray P, Ray V, Rosenthal I.M. Persistent müllerian duct syndrome in a man with transverse testicular ectopia. J Urol. 1988;139(2):373-375.
116. Farag TI. Familial persistent müllerian duct syndrome in Kuwait and neighboring populations. Am J Med Genet. 1993;47(3):432-434.
117. Chemes H, Muzulin PM, Venara MC, Mulhmann M del C, Martinez M, Gamboni M. Early manifestations of testicular dysgenesis in children: pathological phenotypes, karyotyope correlations and precursor stages of tumour development. APMIS. 2003;111(1):12-23.
118. Kropp BP, Keating MA, Moshang T, Duckett JW. True hermaphroditism and normal male genitalia: an unusual presentation. Urology. 1995;46(5):736-739.
119. Nistal M, Paniagua R. Testicular and Epididymal Pathology. New York, Thiemes-Verlag. 1984.
120. Nistal M, Paniagua R. Non-neoplastic diseases of the testis. In Bostwick DG, Eble JN, editors. Urologic Surgical Pathology. St. Louis. Mosby-Year Book Inc. 1997. pp 457-565.
121. Van Niekerk WA, Retief AE. The gonads of human true hermaphrodites. Hum Genet. 1981;58(1):117-122.
122. Pals-Rylaarsdam R, Liu G, Brickman W, Duranteau L, Monroe J, El-Awady MK, et al. A novel double mutation in the luteinizing hormone receptor in a kindred with familial Leydig cell hypoplasia and male pseudohermaphroditism. Endocr Res. 2005;31:307-323.
123. Nistal M, Gonzalez-Peramato P, Paniagua R. Congenital Leydig cell hyperplasia. Histopathology. 1988;12(3):307-317.
124. Regadera J, Martinez-Garcia F, Paniagua R, Nistal M. Androgen insensitivity syndrome: an immunohistochemical, ultrastructural, and morphometric study. Arch Pathol Lab Med. 1999;123(3):225-234.
125. Imperato-McGinley J, Peterson RE, Stoller R, Goodwin WE. Male pseudohermaphroditism secondary to 17-beta hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J Clin Endocrinol Metab. 1979;49 (3):391-395.
126. Nistal M, Paniagua R. Testicular biopsy. Contemporary interpretation. Urol Clin North Am. 1999;26(3):555-593.
127. Oka M, Katabuchi H, Munemura M, Mizumoto J, Maeyama M. An unusual case of male pseudohermaphroditism: complete testicular feminization associated with incomplete differentiation of the Mullerian duct. Fertil Steril. 1984;41(1):154-156.
128. Chryssikopoulos A, Antoniou A, Loghis C. Development of a hypoplastic uterus in a patient with testicular feminization syndrome 21 years after gonadectomy. Ultrasound Obstet Gynecol. 1996;8(4):283-386.
129. Okon E, Livni N, Rosler A, Yorkoni S, Segal S, Kohn G, et al. Male pseudohermaphroditism due to 5 alpha-reductase deficiency. Ultrastructure of the gonads. Arch Pathol Lab Med. 1980;104(7):363-367.
130. Tullu MS, Arora P, Parmar RC, Muranjan MN, Bharucha BA. Ovarian dysgenesis with balanced autosomal translocation. J Postgrad Med. 2001;47(2):113-115.
131. Letterie GS, Page DC. Dysgerminoma and gonadal dysgenesis in a 46,XX female with no evidence of Y chromosomal DNA. Gynecol Oncol. 1995;57(3):423-425.
132. Morimura Y, Nishiyama H, Yanagida K, Sato A. Dysgerminoma with syncytiotrophoblastic giant cells arising from 46,XX pure gonadal dysgenesis. Obstet Gynecol. 1998;92(4 Pt 2):654-656.
133. Hanson L, Bryman I, Janson PO, Jakobsen AM, Hanson C. Fluorescence in situ hybridisation analysis and ovarian histology of women with Turner syndrome presenting with Y-chromosomal material: a correlation between oral epithelial cells, lymphocytes and ovarian tissue. Hereditas. 2002;137(1):1-6.
134. Mazzanti L, Cicognani A, Baldazzi L, Bergamaschi R, Scarano E, Strocchi S, et al. Gonadoblastoma in Turner syndrome and Y-chromosome-derived material. Am J Med Genet A. 2005;135(2):150-154.
135. Kocova M, Basheska N, Papzovska A, Jankova R, Toncheda D, Popovska S. Girls with Turner's syndrome with spontaneous menarche have an increased risk of endometrial carcinoma: a case report and review from the literature. Gynecol Oncol. 2005;96(3):840-845.
136. Le Caignec C, Baron S, McElreavey K, Joubert M, Rival JM, Mechinaud F, et al. 46,XY gonadal dysgenesis: evidence for autosomal dominant transmission in a large kindred. Am J Med Genet A. 2003;116(1):37-43.
137. Hoepffner W, Horn LC, Simon E, Sauerbrei G, Schroeder H, Thamm-Muscke B, et al. Gonadoblastomas in 5 patients with 46,XY gonadal dysgenesis. Exp Clin Endocrinol Diabetes. 2005;113(4):231-235.
138. Ramani P, Yeung CK, Habeebu SSM. Testicular intratubular germ cell neoplasia in children and adolescents with intersex. Am J Surg Pathol. 1993;17(11):1124-1133.
139. Portuondo JA, Neyro JL, Barral A, Gonzalez-Garope F, Benito JA. Management of phenotypic female patients with an XY karyotype. J Reprod Med. 1986;31(7):611-615.
140. Haddad NG, Walvoord EC, Cain MP, Davis MM. Seminoma and a gonadoblastoma in an infant with mixed gonadal dysgenesis. J Pediatr. 2003;143(1):136.
141. Rutgers JL. Advances in the pathology of intersex conditions. Hum Pathol. 1991;22(9):884-891.
142. Nogales FF Jr, Toro M, Ortega I, Fulwood HR. Bilateral incipient germ cell tumours of the testis in the incomplete testicular feminization syndrome. Histopathology. 1981;5(5):511-515.
143. Kocak M, Yalva CS, Pata O, Turan H, Haberal A. A seminoma case which occurred in a patient with familial testicular feminization syndrome. Acta Obstet Gynecol Scand. 2000;79(10):890-891.
144. Baksu A, Kabukcuoglu F, Baksu B, Goker N. Bilateral Sertoli cell adenoma and serous cyst in a patient with androgen insensitivity syndrome. Eur J Obstet Gynecol Reprod Biol. 2004;114(1):104-107.
145. Buchholz NP, Biyebani R, Herzig MJU, Ali A, Nazir Z, Sulaiman MN, et al. Persistent müllerian duct syndrome. Eur Urol. 1998;34(3):230-232.
146. Nistal M, Paniagua R, Isorna S, Mancebo J. Diffuse intratubular undifferentiated germ cell tumor in both testes of a male subject with a uterus and ipsilateral testicular dysgenesis. J Urol. 1980;124(2):286-289.
147. Dueñas A, Saldivar C, Castillero C, Flores G, Martinez P, Jimenez M. A case of bilateral seminoma in the setting of persistent mullerian duct syndrome. Rev Invest Clin. 2001;53(2):193-196.
148. Imbeaud S, Belville C, Messika-Zeitoun L, Rey R, Di Clemente N, Josso N, et al. A 27 base-pair deletion of the anti-Múllerian type II receptor gene is the most common cause of the persistent Müllerian duct syndrome. Hum Mol Genet. 1996;5(9):1269-1277.
149. Shinmura Y, Yokoi T, Tsutsui Y. A case of clear cell adenocarcinoma of the mullerian duct in persistent mullerian duct syndrome: the first reported case. Am J Surg Pathol. 2002;26(9):1231-1234.
150. Mitre AI, Castilho LN, Avarese de Figueiredo A, Arap S. Persistent mullerian duct syndrome and prostate cancer. Urology. 2002;60(4):698.
151. Vandersteen DR, Chaumeton AK, Ireland K, Tank ES. Surgical management of persistent müllerian duct syndrome. Urology. 1997;49(6):941-945.
152. Kazim E. Intra-abdominal seminomas in persistent müllerian duct syndrome. Urology. 1985;26(3):290-292.
153. Krob G, Braun A, Kuhnle U. True hermaphroditism: geographical distribution, clinical findings, chromosomes and gonadal histology. Eur J Pediatr 1994;153(1):2-10.
154. Malavaud B, Mazerolles C, Bieth E, Chevreau C, Le Frere M-A, Alric L. Pure seminoma in a male phenotype 46,XX true hermaphrodite. J Urol 2000;164(1):125-126.
155. Esen T, Erdogru T, Müslümanoglu M, Kiliçaslan I, Kaiserili H. Laparoscopic removal of uterus, seminal vesicle and bilateral ovotestes harboring mature teratoma and carcinoid tumor in an intersex patient. J Urol. 1996;155(6):2032-2033.